TIGIT/CD226 Axis Regulates Anti-Tumor Immunity
Tumors escape immune surveillance by inducing various immunosuppressive pathways, including the activation of inhibitory receptors on tumor-infiltrating T cells. While monoclonal antibodies (mAbs) blocking programmed cell death 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T lymphocyte-...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2021-02-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/14/3/200 |